431
Views
36
CrossRef citations to date
0
Altmetric
Reviews

The preventive and therapeutic potential of natural polyphenols on influenza

, , , , &

References

  • Papers of special note have been highlighted as:
  • •• of considerable interest
  • Medina RA, García-Sastre A. Influenza a viruses: new research developments. Nat Rev Microbiol. 2011;9(8):590–603.
  • Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis. 2006;194(2):S73–76.
  • Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol. 2014;385:359–375.
  • Available from: http://www.hort.purdue.edu/newcrop/hort_306/reading/reading%204-3.pdf
  • Kradin RL, Fishman JA. Influenza virus. In: Fraire AE, Woda BA, Welsh RM, Kardin RL, editors. Viruses and the lung. Berlin: Springer; 2014. p. 79–86.
  • Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006;194(Suppl 2):S82–91.
  • Grijalva CG, Weinberg GA, Bennett NM, et al. Estimating the undetected burden of influenza hospitalizations in children. Epidemiol Infect. 2007;135(6):951–958.
  • Pang IK, Iwasaki A. Inflammasomes as mediators of immunity against influenza virus. Trends Immunol. 2011;32(1):34–41.
  • La Gruta NL, Turner SJ. T cell mediated immunity to influenza: mechanisms of viral control. Trends Immunol. 2014;35(8):396–402.
  • Gooshe M, Abdolghaffari AH, Gambuzza ME, et al. The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes. Rev Neurosci. 2014;25(5):713–739.
  • Gooshe M, Aleyasin AR, Abdolghaffari AH, et al. Toll like receptors: a new hope on the horizon to treat multiple sclerosis. Expert Rev Clin Immunol. 2014;10(10):1277–1279.
  • Huang KY, Li CK, Clutterbuck E, et al. Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. J Infect Dis. 2014;209(9):1354–1361.
  • Farzaei MH, Farzaei F, Gooshe M, et al. Potentially effective natural drugs in treatment for the most common rheumatic disorder: osteoarthritis. Rheumatol Int. 2015;35:799–814.
  • Neurath AR, Strick N, Li YY, et al. Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect Dis. 2004;4:41.
  • Yamaguchi K, Honda M, Ikigai H, et al. Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 2002;53:19–34.
  • Danne A, Petereit F, Nahrstedt A. Proanthocyanidins from Cistus incanus. Phytochemistry. 1993;14:1129–1133.
  • Kamin W, Maydannik V, Malek FA, et al. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis – a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots. Int J Clin Pharmacol Ther. 2010;48:184–191.
  • Osaka K, Hoshina S, Nakamura S, et al. Cholesterol oxidation in meat products and its regulation by supplementation of sodium nitrite and apple polyphenol before processing. J Agric Food Chem. 2000;48:3823–3829.
  • Huang KL, Lai YK, Lin CC, et al. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. World J Gastroenterol. 2006;12(35):5721–5725.
  • Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75:311−35.
  • Serkedjieva J. Influenza virus variants with reduced susceptibility to inhibition by a polyphenol extract from Geranium sanguineum L. Pharmazie. 2003;58:53–58.
  • Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2(5):270–278.
  • Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010;2:1231–1246.
  • Farzaei MH, Abdollahi M, Rahimi R. Role of dietary polyphenols in the management of peptic ulcer. World J Gastroenterol. 2015;21(21):6499–6517.
  • Dubick MA, Omaye ST. Evidence for grape, wine and tea polyphenols as modulators of atherosclerosis and ischemic heart disease in humans. J Nutraceut Functional Med Foods. 2001;3:67–93.
  • Singh M, Arseneault M, Sanderson T, et al. Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem. 2008;56:4855–4873.
  • Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Ann Rev Nutr. 2001;21:381–406.
  • Rizvi SI, Zaid MA. Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes: effect of Insulin and (-) epicatechin. J Physiol Pharmacol. 2001;52:483–488.
  • Bouamama H, Villard J, Benharref A, et al. Antibacterial andantifungal activities of Cistus incanus and C.monspeliensis leaf extracts. Therapie. 1999;54:731–733.
  • Nantz MP, Rowe CA, Muller C, et al. Consumption of cranberry polyphenols enhances human γδ-T cell proliferation and reduces the number of symptoms associated with colds and influenza: a randomized, placebo-controlled intervention study. Nutr J. 2013;12:161.

•• Provides clinical study of anti-influenza effects of cranberry in different age and sex.

  • Sodagari HR, Farzaei MH, Bahramsoltani R, et al. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2015;13:1–14.
  • Petereit F, Kolodziej H, Nahrstedt A. Flavan-3-ols and proanthocyani-dins from Cistus incanus. Phytochemistry. 1991;30:981–985.
  • Ehrhardt C, Hrincius ER, Korte V, et al. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virusactivity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res. 2007;76:38–47.
  • Droebner K, Ehrhardt C, Poetter A, et al. CYSTUS052, a polyphenol-rich plant extract,exerts anti-influenza virus activity in mice. Antiviral Res. 2007;76:1–10.

•• Provides useful information about the both in vitro and in vivo anti-influenza activity of CYSTUS052.

  • Kalus U, Grigorov A, Kadecki O, et al. Cistus incanus (CYSTUS052) for treating patients with infectionof the upper respiratory tractA prospective, randomised, placebo-controlled clinical study. Antiviral Res. 2009;84:267–271.
  • Dao TT, Nguyen PH, Won HK. Curcuminoids from Curcuma longa and their inhibitory activities on influenza A neuraminidases. Food Chem. 2012;134(1):21–28.
  • Nakayama M, Suzuki K, Toda M, et al. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993;21:289–299.
  • Yang ZF, Bai LP, Huang WB, et al. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis. Fitoterapia. 2014;93:47–53.

•• Gives comprehensive information about anti-influenza activity of tea polyphenols.

  • Ryu YB, Kim JH, Park SJ, et al. Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg Med Chem Lett. 2010;20:971–974.
  • Park S, Kim JI, Lee I, et al. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses. Biochem Biophys Res Commun. 2013;440:14–19.
  • Sithisarn P, Michaelis M, Schubert-Zsilavecz M. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells. Antiviral Res. 2013;97(1):41–48.
  • Lei G, Hong-shan C. Inhibiting effect of baicalin on influenza, herpes simplex and CoxB_3 virus infections in cultured cells. Chin J New Drugs. 2008;17(6):474–478.
  • Nayak MK, Agrawal AS, Bose S, et al. Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. J Antimicrob Chemother. 2014;69(5):1298–1310.
  • Sawai R, Kuroda K, Shibata T, et al. Anti- influenza virus activity of Chaenomeles sinensis. J Ethnopharmacol. 2008;118:108–112.
  • Sawai-Kuroda R, Kikuchi S, Shimizu YK, et al. A polyphenol-rich extract from Chaenomeles sinensis (Chinesequince) inhibits influenza A virus infection by preventing primary transcription in vitro. J Ethnopharmacol. 2013;146:866–872.
  • Chen DY, Shien JH, Tiley L. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010;119(4):1346–1351.
  • Chen TY, Chen DY, Wen HW. Inhibition of enveloped viruses infectivity by curcumin. PLoS One. 2013;8(5):e62482.
  • Mori S, Miyake S, Kobe T, et al. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length. Bioorg Med Chem Lett. 2008;18:4249–4252.
  • Theisen LL, Muller CP. EPs 7630 (Umckaloabo), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral Res. 2012;94:147–156.
  • Kuzuhara T, Iwai Y, Takahashi H. Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr. 2009;1:RRN1052.
  • Imanishi N, Tuji Y, Katada Y, et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol. 2002;46:491–494.
  • Kim Y, Narayanan S, Chang K. Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Res. 2010;88:227–235.
  • Gangehei L, Ali M, Zhang W, et al. Oligonol a low molecular weight polyphenol of lychee fruit extract inhibits proliferation of influenza virus by blocking reactive oxygen species-dependent ERK phosphorylation. Phytomedicine. 2010;17:1047–1056.
  • Serkedjieva J, Nikolova E, Kirilov N. Synergistic inhibition of influenza A virus replication by a plant polyphenol-rich extract and ε-aminocaproic acid in vitro and in vivo. Acta Virol. 2010;54:137–145.
  • Sundararajan A, Ganapathy R, Huan L, et al. Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins. Antiviral Res. 2010;88:1–9.
  • Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005;68:66–74.
  • Serkedjieva J, Hay AJ. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antiviral Res. 1998;37:121–130.
  • Sokmen M, Angelova M, Krumova E, et al. In vitro antioxidant activity of polyphenol extracts with antiviral properties from Geranium sanguineum L. Life Sciences. 2005;76:2981–2993.
  • Haidari M, Ali M, Ward Casscells S 3rd, et al. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine. 2009;16:1127–1136.
  • Choi HJ, Song JH, Park KS, et al. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci. 2009;37(3–4):329–333.
  • Palamara AT, Nencioni L, Aquilano K, et al. Inhibition of influenza A virus replication by resveratrol. J Infect Dis. 2005;191(10):1719–1729.
  • Ueda K, Kawabata R, Irie T, et al. Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a Broad Range of Viruses. PLoS ONE. 2013;8(1):e55343.
  • Zu M, Yang F, Zhou W, et al. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives. Antiviral Res. 2012;94:217–224.
  • Doijode SD. Seed storage of horticultural crops. New York (NY): Food Products Press; 2001.
  • Sheidai M, Kolahizadeh S, Noormohammadi Z, et al. Correlation between geography and cytogenetic diversity in Pomegranate (Punica granatum L.) cultivars in Iran. Acta Bot Bras. 2012;26(4):953–965.
  • Gil MI, Tomas-Barberan FA, Hess-Pierce B, et al. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000;48:4581–4589.
  • Tzulker R, Glazer I, Bar-Ilan I, et al. Antioxidant activity, polyphenol content, and related compounds indifferent fruit juices and homogenates prepared from 29 different pomegranate accessions. J Agric Food Chem. 2007;55:9559–9570.
  • Lansky EP, Newman RA. Punica granatum (pomegranate) and its potentialfor prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109:177–206.
  • Reddy MK, Gupta SK, Jacob MR, et al. Antioxidant, anti-malarial and antimicrobial activities of tannin-rich fractions, ellagitannins andphenolic acids from Punica granatum L. Planta Med. 2007;73:461–467.
  • Kitadate K, Aoyagi K, Homma K. Effect of Lychee Fruit Extract (Oligonol) on Peripheral Circulation, a Pilot Study. Nat Med J. 2014;6:7.
  • Sarni-Manchado P, Le Roux E, Le Guerneve C, et al. Phenolic composition of litchi fruit pericarp. J Agric Food Chem. 2000;48(12):5995–6002.
  • Sakurai T, Nishioka H, Fujii H, et al. Antioxidative effects of a new lychee fruit-derived polyphenol mixture, oligonol, converted into a low-molecular form in adipocytes. Biosci Biotechnol Biochem. 2008;72(2):463–466.
  • Nagasawa J, Sugiyama K, Uchimaru J, et al. Oxidative stress in hypobaric and normobaric hypoxia and antioxidant effect of Oligonol. Japan J Mountain Med. 2010;30:118–124.
  • Moriwaki Y, Okuda C, Yamamoto A, et al. Effects of Oligonol, an oligomerized polyphenol formulated from lychee fruit on serum concentration and urinary excretion of uric acid. J Funct Foods. 2011;3(1):13–16.
  • Kang SW, Hahn S, Kim JK, et al. Oligomerized lychee fruit extract (OLFE) and a mixture of vitamin C and vitamin E for endurance capacity in a double blind randomized controlled trial. J Clin Biochem Nutr. 2012;50(2):106–113.
  • Ohno H, Sakurai T, Hisajima T, et al. The supplementation of Oligonol, the new lychee fruit-derived polyphenol converting into a low-molecular form, has a positive effect on fatigue during regular track-and-field training in young athletes. Adv Exerc Sports Physiol. 2008;13(4):93–99.
  • Nishihira J, Sate-Ueshima M, Kitadate K, et al. Amelioration of abdominal obesity by low-molecular-weight polyphenol (Oligonol) from lychee. J Funct Foods. 2009;1(4):341–348.
  • Lee JB, Shin YO, Min YK, et al. The effect of Oligonol intake on cortisol and related cytokines in healthy young men. Nutr Res Pract. 2010;4(3):203–207.
  • Nishizawa M, Hara T, Miura T, et al. Supplementation with a flavanol-rich lychee fruit extract influences the inflammatory status of young athletes. Phytother Res. 2011;25(10):1486–1493.
  • Brendler T, van Wyk BE. A historical, scientific and commercial perspectiveon the medicinal use of Pelargonium sidoides (Geraniaceae). J Ethnopharmacol. 2008;119:420–433.
  • Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine. 2008;15:378–385.
  • Matthys H, Eisebitt R, Seith B, et al. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine. 2003;10(Suppl. 4):7–17.
  • Matthys H, Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study. Curr Med Res Opin. 2007;23:323–331.
  • Schötz K, Nöldner M. Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models. Phytomedicine. 2007;14(Suppl. 6):32–39.
  • Schoetz K, Erdelmeier C, Germer S, et al. A detailed view on the constituents of EPs 7630. Planta Med. 2008;74:667–674.
  • Vuong QV, Stathopoulos CE, Nguyen MH, et al. Isolation of green tea catechins and their utilization in the food industry. Food Rev Int. 2011;27:227–247.
  • Steinmann J, Buer J, Pietschmann T. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol. 2013;168(5):1059–1073.
  • Valcic S, Muders A, Jacobsen NE, et al. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (−)-epigallocatechin gallate with peroxyl radicals. Chem Res Toxicol. 1999;12:382–386.
  • Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89–143.
  • Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys. 2010;501:65–72.
  • Toda M, Okubo S, Ikigai H, et al. The protective activity of tea catechins against experimental infection by Vibrio cholera O1. Microbiol Immunol. 1992;36:999–1001.
  • Gensler HL, Timmermann BN, Valcic S, et al. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated fromgreen tea. Nutr Cancer. 1996;26:325–335.
  • Mimoto J, Kiura K, Matsuo K, et al. (−)-Epigallocatechin gallate can prevent cisplatin induced lung tumorigenesis in A/J mice. Carcinogenesis. 2000;21:915–919.
  • Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42:25–54.
  • Mukhtar H, Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr. 2000;71:1698S–1702S.
  • Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003;133:3262S–3267S.
  • Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 2008;269:269–280.
  • Yang CS, Wang X. Green tea and cancer prevention. Nutr Cancer. 2010;62:931–937.
  • Fassina G, Buffa A, Benelli R, et al. Polyphenolic antioxidant (−)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. Aids. 2002;16:939–941.
  • Nakane H, Ono K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases and various DNA and RNA polymerases by some catechin derivatives. Biochemistry. 1990;29:2841–2845.
  • Huang HC, Lin JK. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food Funct. 2012;3:170–177.
  • Yamada H, Takuma N, Daimon T, et al. Gargling with Tea Catechin Extracts for the Prevention of Influenza Infection in Elderly Nursing Home Residents: A Prospective Clinical Study. J Altern Complement Med. 2006;12(7):669–672.
  • Matsumoto K, Yamada H, Takuma N, et al. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med. 2011;11:15.
  • Pantev A, Ivancheva S, Staneva L, et al. Biologically active constituents of a polyphenol extract from Geranium sanguineum L. with antiviral activity. Z Naturforsch. 2006;61c:508–516.
  • Serkedjieva J, Manolova N. Plant polyphenol complex inhibits the reproduction of influenza and herpes simplex viruses. Basic Life Sci. 1992;59:705–715.
  • Ivancheva S, Stancheva B, Serkedjieva J. Polyphenol compounds in Geranium sanguineum L. C R Acad Bulg Sci. 1996;49:41–43.
  • Serkedjieva J, Stefanova T, Krumova E. A Fungal Cu/Zn-containing superoxide dismutase enhances the therapeutic efficacy of a plant polyphenol extract in experimental influenza virus infection. Z Naturforsch C. 2010;65(5–6):419–428.
  • Serkedjieva J, Toshkova R, Stefanova T, et al. Effect of a plant polyphenol-rich extract on the lung protease activities of influenza-virus-infected mice. Antiviral Chem Chemother. 2007;18:75–82.
  • Ivanova E, Toshkova R, Serkedjieva J. A plant polyphenol-rich extract restores the suppressed functions of phagocytes in influenza virus-infected mice. Microbes Infect. 2005;7:391–398.
  • Serkedjieva J, Gegova G, Mladenov K. Protective efficacy of an aerosol preparation, obtained from Geranium sanguineum L., in experimental influenza infection. Pharmazie. 2008;63(2):160–163.
  • Valcheva-Kuzmanova SV, Belcheva A. Current knowledge of Aronia melanocarpa as a medicinal plant. Folia Med (Plovdiv). 2006;48:11–17.
  • Wu X, Gu L, Prior RL, et al. Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia and Sambucus and their antioxidant capacity. J Agric Food Chem. 2004;52(26):7846–7856.
  • Taheri R, Connolly BA, Brand MH, et al. Underutilized chokeberry (Aronia melanocarpa, Aronia arbutifolia, Aronia prunifolia) accessions are rich sources of anthocyanins, flavonoids, hydroxycinnamic acids, and proanthocyanidins. J Agric Food Chem. 2013;61(36):8581–8588.
  • Neveu V, Perez-Jiménez J, Vos F, et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database. 2010;2010:bap024.
  • Rugină D, Sconţa Z, Leopold L, et al Antioxidant activities of chokeberry extracts and the cytotoxic action of their anthocyanin fraction on He La human cervical tumor cells. J Med Food. 2012;15(8):700–706.
  • Zapolska-Downar D, Bryk D, Małecki M, et al. Aronia melanocarpa fruit extract exhibits anti-inflammatory activity in human aortic endothelial cells. Eur J Nutr. 2012;51(5):563–572.
  • Ohgami K, Ilieva I, Shiratori K, et al. Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2005;46(1):275–281.
  • Kim B, Ku CS, Pham TX, et al. Aronia melanocarpa (chokeberry) polyphenol–rich extract improves antioxidant function and reduces total plasma cholesterol in apolipoprotein E knockout mice. Nutr Res. 2013;33(5):406–413.
  • Valcheva-Kuzmanova S, Marazova K, Krasnaliev I, et al. Effect of Aronia melanocarpa fruit juice on indomethacin-induced gastric mucosal damage and oxidative stress in rats. Exp Toxicol Pathol. 2005;56(6):385–392.
  • Valcheva-Kuzmanova S, Borisova P, Galunska B, et al. Hepatoprotective effect of the natural fruit juice from Aronia melanocarpa on carbon tetrachloride-induced acute liver damage in rats. Exp Toxicol Pathol. 2004;56(3):195–201.
  • Kedzierska M, Olas B, Wachowicz B, et al. An extract from berries of Aronia melanocarpa modulates the generation of superoxide anion radicals in blood platelets from breast cancer patients. Planta Medica. 2009;75(13):1405–1409.
  • Naruszewicz M, Łaniewska I, Millo B, et al. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infarction (MI). Atherosclerosis. 2007;194(2):e179–84.
  • Broncel M, Kozirog M, Duchnowicz P, et al. Aronia melanocarpa extract reduces blood pressure, serum endothelin, lipid, and oxidative stress marker levels in patients with metabolic syndrome. Med Sci Monit. 2010;16(1):CR28–34.
  • Wu XN, Yu CH, Cai W, et al. Protective effect of a polyphenolic rich extract from Magnolia officinalis bark on influenza virus-induced pneumonia in mice. J Ethno Pharmacol. 2011;134:191–194.
  • Lee SJ, Cho YH, Park K. Inhibitory effects of the aqueous extract of Magnolia officinalis on the responses of human urinary bladder cancer 5637 cells in vitro and mouse urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in vivo. Phytother Res. 2009;23:20–27.
  • Lin YR, Chen HH, Ko CH, et al. Effects of honokiol and magnolol on acute and inflammatory pain models in mice. Life Sciences. 2007;81:1071–1078.
  • Shen CC, Ni CL, Shen YC. Phenolic constituents from the stem bark of Magnolia officinalis. J Nat Prod. 2009;72:168–171.
  • Xu Q, Yi LT, Pan Y. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:715–725.
  • Yin HQ, Je YT, Kim YC. Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c. J Pharmacol Sci. 2009;109:486–495.
  • Akiyama H, Sakushima J, TaniuchiI S, et al. Antiallergic effect of apple polyphenols on the allergic model mouse. Biol Pharm Bull. 2000;23:1370–1373.
  • Yanagida A, Kanda T, Tanabe M, et al. Inhibitory effects of apple polyphenols and related compounds on cariogenic factors of mutans streptococci. J Agric Food Chem. 2000;48:5666–5671.
  • He RR, Wang M, Wang CZ, et al. Protective effect of apple polyphenols against stress-provoked influenza viral infection in restraint mice. J Agric Food Chem. 2011 27;59(8):3730–3737.
  • Veeriah S, Kautenburger T, Habermann N, et al. Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobiotics. Mol Carcinog. 2006;45(3):164–174.
  • Yang G, Fen W, Xiao W. Study on determination of pentacyclic triterpenoids in Chaenomeles by HPLC-ELSD. J Chromatogr Sci. 2009;47(8):718–722.
  • Zheng J, Ding C, Wang L, et al. Anthocyanins composition and antioxidant activity of wild Lycium ruthenicum Murr. from Qinghai-Tibet Plateau. Food Chem. 2011;126(3):859–865.
  • Sawai-Kuroda R, Sasaki Y, Nishikawa T, et al. Antiviral activityof Chaenomeles sinensis against influenza A/Chiba/1001/2009(H1N1) pdm virus. Nippon Shokuhin Kagaku Kougaku Kaishi (J Jpn Soc Food Sci). 2011;58:496–498.
  • Asada Y, Li W, Yoshikawa T. Biosynthesis of the dimethylallyl moiety of glabrol in Glycyrrhiza glabra hairy root cultures via a non-mevalonate pathway. Phytochemistry. 2000;55(4):323–326.
  • Kamei J, Nakamura R, Ichiki H, et al. Antitussive principles of Glycyrrhizae radix, a main component of the Kampo preparations Bakumondo-to (Mai-men-dong-tang). Eur J Pharmacol. 2003;469(1–3):159–163.
  • Zore GB, Winston UB, Surwase BS, et al. Chemoprofile and bioactivities of Taverniera cuneifolia (Roth) Arn.: a wild relative and possible substitute of Glycyrrhiza glabra L. Phytomedicine. 2008;15(4):292–300.
  • Liang RJ. Orthogonal test design for optimization of the extraction of polysaccharides from Phascolosoma esulenta and evaluation of its immunity activity. Carbohydr Polym. 2008;73:558–563.
  • Dong S, Inoue A, Zhu Y, et al. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root. Food Chem Toxicol. 2007;45:2470–2478.
  • Mahady GB, Fong HHS, Farnsworth NR. Cranberry. In: Botanical dietary supplements: quality, safety and efficacy. Lisse (The Netherlands): Swets Publishing; 2001. p. 23–35.
  • Mahady GB, Fong HHS, Farnsworth NR. WHO Monographs on Selected Medicinal Plants. Vol. 4. Geneva (Switzerland): WHO Publications. Fructus Macrocarponii; 2008. p. 132–147.
  • Jepson R, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2001;3:CD001321.
  • Jass J, Reid G. Effect of cranberry drink on bacterial adhesion in vitro and vaginal microbiota in healthy females. Can J Urol. 2009;16:4901–4907.
  • Vinson JA, Bose P, Proch J, et al. Cranberries and cranberry products: powerful in vitro, ex vivo, and in vivo sources of antioxidants. J Agric Food Chem. 2008;56:5884–5891.
  • Huang Y, Nikolic D, Pendland S, et al. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional response in vitro. Pharm Biol. 2009;47:18–25.
  • Cimolai N, Cimolai T. The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis. 2007;26:767–776.
  • Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res. 2006;85(3):235–239.
  • Chandra A, Rana J, Li Y. Separation, identification, quantification, and method validation of anthocyanins in botanical supplement raw materials by HPLC and HPLC-MS. J Agric Food Chem. 2001;49:3515–3521.
  • Inami O, Tamura I, Kikuzaki H, et al. Stability of anthocyanins of Sambucus Canadensis and Sambucus nigra. J Agric Food Chem. 1996;44:3090–3096.
  • Nakatani N, Kikuzaki H, Hikida J, et al. Acylated anthocyanins from fruits of Sambucus canadensis. Phytochemistry. 1995;38:755–757.
  • Kilham C. Health benefits boost elderberry. Herbal Gram. 2000;50:55–57.
  • Kilham C. Elderberries grow beyond folklore into mainstream functional foods. Prepared Foods. 2001;39–41.
  • Zakay-Rones Z, Varsano N, Zlotnik M, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995;1(4):361–369.
  • Serrano J, Puupponen-Pimia R, Dauer A, et al. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res. 2009;53(Suppl 2):S310–29.
  • Jeandet P, Bessis R, Gautheron B. The production of resveratrol (3,5,4 -trihydroxystilbene) by grape berries in different developmental stages. Am J Enol Vitic. 1991;42:41.
  • Gulcin L. Antioxidant properties of resveratrol: a structure-activity insight, Innov. Food Sci Emerg Tech. 2010;11:210–218.
  • Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol. 2000;59:865–870.
  • Bai Y, Mao QQ, Qin J, et al. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010;101:488–493.
  • Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014;21(3):R209–225.
  • Wu JM, Wang ZR, Hsieh TC, et al. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med. 2001;8:3–17.
  • Tomé-Carneiro J, Gonzálvez M, Larrosa M, et al. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci. 2013;1290:37–51.
  • Docherty JJ, Smith JS, Fu MM, et al. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Res. 2004;61:19–26.
  • Heredia A, Davis C, Redfield R. Synergistic inhibition of HIV-1 inactivated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J Acquir Immune Defic Syndr. 2000;25:246–255.
  • Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. Int J Med Update. 2007;2(2):22–37.
  • Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130(8S Suppl):2073S–2085.
  • Silva BA, Malva O, Dias AC. St. John’s Wort (Hypericum perforatum) extracts and isolated phenolic compounds are effective antioxidants in several in vitro models of oxidative stress. Food Chem. 2008;110:611–661.
  • Zhang R, Yao Y, Wang Y, et al. Antidiabetic activity of isoquercetin in diabetic KK-Ay mice. Nutr Metab. 2011;8:85.
  • Thapa M, Kim Y, Desper J, et al. Synthesis and Antiviral Activity of Substituted Quercetins. Bioorg Med Chem Lett. 2012;22(1):353–356.
  • Davis JM, Murphy EA, McClellan JL, et al. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol Regul Integr Comp Physiol. 2008;295(2):R505–509.
  • Kumar P, Khanna M, Srivastava V, et al. Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection. Exp Lung Res. 2005;31(5):449–459.
  • Savov VM, Galabov AS, Tantcheva LP, et al. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection. Exp Toxicol Pathol. 2006;58(1):59–64.
  • Xu G, Dou J, Zhang L, et al. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol Pharm Bull. 2010;33(2):238–243.
  • Satpathy R, Guru RK, Behera R. Evaluation of anti-influenza activity of curcumin derivatives by docking and pharmacophore modeling approach. Int J Pharm Pharm Sci. 2012;4(1):469–473.
  • Prasad NR, Karthikeyan A, Karthikeyan S, et al. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem. 2011;349(1–2):11–19.
  • Olthof MR, Hollman PC, Katan MB, et al. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001;131(1):66–71.
  • Touaibia M, Jean-Francois J, Doiron J. Caffeic Acid, a versatile pharmacophore: an overview. Mini Rev Med Chem. 2011;11(8):695–713.
  • Kashiwada Y, Ahmed FA, Kurimoto S, et al. New α-glucosides of caffeoyl quinic acid from the leaves of Moringa oleifera Lam. J Nat Med. 2012;66(1):217–221.
  • Liu KC, Fang JM, Jan JT, et al. Enhanced anti-influenza agents conjugated with anti inflammatory activity. J Med Chem. 2012;55(19):8493–8501.
  • Xie Y, Huang B, Yu K, et al. Caffeic acid derivatives: A new type of influenza neuraminidase inhibitors. Bioorg Med Chem Lett. 2013;23:3556–3560.
  • Yang J, Yang JX, Zhang F, et al. Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H5N1. Bioorg Med Chem Lett. 2014;24:2680–2684.
  • Stiver G. The treatment of influenza with antiviral drugs. Can Med Assoc J. 2003;168(1):49–57.
  • Vlahos R, Selemidis S. NADPH oxidases as novel pharmacologic targets against influenza A virus infection. Mol Pharmacol. 2014;86(6):747–759.
  • Shatynski KE, Chen H, Kwon J, et al. Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper development. Eur J Immunol. 2012;42(12):3202–3211.
  • Rietjens IM, Boersma MG, Haan L, et al. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ Toxicol Pharmacol. 2002;11(3–4):321–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.